- Home
- SKYE vs TWIN Comparison
SKYE vs TWIN Comparison
Compare SKYE & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- TWIN
- Stock Information
- Founded
- SKYE 2012
- TWIN 1918
- Country
- SKYE United States
- TWIN United States
- Employees
- SKYE N/A
- TWIN N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- TWIN Industrial Machinery/Components
- Sector
- SKYE Health Care
- TWIN Industrials
- Exchange
- SKYE Nasdaq
- TWIN Nasdaq
- Market Cap
- SKYE 121.8M
- TWIN 186.2M
- IPO Year
- SKYE N/A
- TWIN N/A
- Fundamental
- Price
- SKYE $1.38
- TWIN $14.45
- Analyst Decision
- SKYE Strong Buy
- TWIN Strong Buy
- Analyst Count
- SKYE 5
- TWIN 1
- Target Price
- SKYE $14.75
- TWIN $12.00
- AVG Volume (30 Days)
- SKYE 1.8M
- TWIN 39.9K
- Earning Date
- SKYE 11-06-2025
- TWIN 11-05-2025
- Dividend Yield
- SKYE N/A
- TWIN 1.11%
- EPS Growth
- SKYE N/A
- TWIN N/A
- EPS
- SKYE N/A
- TWIN N/A
- Revenue
- SKYE N/A
- TWIN $340,738,000.00
- Revenue This Year
- SKYE N/A
- TWIN $10.79
- Revenue Next Year
- SKYE N/A
- TWIN $8.43
- P/E Ratio
- SKYE N/A
- TWIN N/A
- Revenue Growth
- SKYE N/A
- TWIN 15.46
- 52 Week Low
- SKYE $1.14
- TWIN $6.16
- 52 Week High
- SKYE $5.96
- TWIN $15.12
- Technical
- Relative Strength Index (RSI)
- SKYE 27.45
- TWIN 56.46
- Support Level
- SKYE $1.50
- TWIN $14.11
- Resistance Level
- SKYE $1.76
- TWIN $15.00
- Average True Range (ATR)
- SKYE 0.24
- TWIN 0.65
- MACD
- SKYE -0.18
- TWIN -0.09
- Stochastic Oscillator
- SKYE 0.00
- TWIN 52.84
About SKYE Skye Bioscience Inc.
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.